219 related articles for article (PubMed ID: 15499700)
1. Fluoroquinolones in children: poorly defined risk of joint damage.
Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700
[TBL] [Abstract][Full Text] [Related]
2. [On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data)].
Postnikov SS; Semykin SIu; Nazhimov VP; Novichkova GA
Antibiot Khimioter; 2002; 47(9):14-7. PubMed ID: 12619515
[TBL] [Abstract][Full Text] [Related]
3. Indications and restrictions of fluoroquinolone use in children.
Green SD
Br J Hosp Med; 1996 Oct 16-Nov 5; 56(8):420-3. PubMed ID: 8909718
[TBL] [Abstract][Full Text] [Related]
4. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
Postnikov SS
Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276
[TBL] [Abstract][Full Text] [Related]
5. Adverse reactions and interactions of fluoroquinolones.
Ball P
Clin Invest Med; 1989 Feb; 12(1):28-34. PubMed ID: 2646053
[TBL] [Abstract][Full Text] [Related]
6. Risks associated with the therapeutic use of fluoroquinolones.
Stahlmann R; Lode HM
Expert Opin Drug Saf; 2013 Jul; 12(4):497-505. PubMed ID: 23651367
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin: new preparation. A me-too with more cardiac risks.
Prescrire Int; 2002 Dec; 11(62):168-9. PubMed ID: 12469694
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin use: acute arthropathy and long-term follow up.
Karande S; Kshirsagar NA
Indian Pediatr; 1996 Nov; 33(11):910-6. PubMed ID: 9141825
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolones in ambulatory ENT and respiratory tract infections: rarely appropriate.
Prescrire Int; 2003 Feb; 12(63):26-7. PubMed ID: 12602405
[TBL] [Abstract][Full Text] [Related]
10. Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.
Chevais M; Reinert P; Rondeau MC; Tobelem R; Albengres E; Riant P; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):306-9. PubMed ID: 3476471
[TBL] [Abstract][Full Text] [Related]
11. Safety profile of quinolone antibiotics in the pediatric population.
Grady R
Pediatr Infect Dis J; 2003 Dec; 22(12):1128-32. PubMed ID: 14688586
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin for the treatment of uncomplicated gonorrhea infection in adolescents: does the benefit outweigh the risk?
Burstein GR; Berman SM; Blumer JL; Moran JS
Clin Infect Dis; 2002 Oct; 35(Suppl 2):S191-9. PubMed ID: 12353206
[TBL] [Abstract][Full Text] [Related]
13. The use of systemic fluoroquinolones.
Committee on Infectious Diseases
Pediatrics; 2006 Sep; 118(3):1287-92. PubMed ID: 16951028
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective survey of fluoroquinolone use in children].
Pariente-Khayat A; Vauzelle-Kervroedan F; d'Athis P; Bréart G; Gendrel D; Aujard Y; Olive G; Pons G
Arch Pediatr; 1998 May; 5(5):484-8. PubMed ID: 9759180
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone antibiotics in infants and children.
Schaad UB
Infect Dis Clin North Am; 2005 Sep; 19(3):617-28. PubMed ID: 16102652
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity anaphylactoid reaction to pefloxacin in a patient with AIDS.
al-Hedaithy MA; Noreddin AM
Ann Pharmacother; 1996 Jun; 30(6):612-4. PubMed ID: 8792948
[TBL] [Abstract][Full Text] [Related]
17. [Neurologic side effects of fluoroquinolones. Apropos of 9 cases concerning pefloxacin].
Andrejak M; Schmit JL; Tondriaux A; Hary L; Debailleux S; Moore N
Therapie; 1992; 47(5):415-8. PubMed ID: 1299981
[TBL] [Abstract][Full Text] [Related]
18. [Arthropathies following the administration of pefloxacin to an adolescent with mucoviscidosis].
Kesseler A; Lacassie A; Hugot JP; Talon P; Thomas D; Astier L
Ann Pediatr (Paris); 1989 Apr; 36(4):275-8. PubMed ID: 2742312
[TBL] [Abstract][Full Text] [Related]
19. [A case of joint toxicity from pefloxacin in the treatment of nephrotic syndrome in a child].
Diouf B; Djoneidi M; Niang A; Diallo S; Moreira-Diop T; Bao O
Dakar Med; 1996; 41(2):105-7. PubMed ID: 9827103
[TBL] [Abstract][Full Text] [Related]
20. Effects of ciprofloxacin on joint cartilage in immature dogs immediately after dosing and after a 5-month treatment-free period.
von Keutz E; Rühl-Fehlert C; Drommer W; Rosenbruch M
Arch Toxicol; 2004 Jul; 78(7):418-24. PubMed ID: 15014927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
